Discounted Cash Flow
Autolus Therapeutics Plc. ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $75.0k | $-12.6m | $-11.7m | -16733.3% | $-1.26 |
| 2017 | $84.0k (12.0%) | $-19.7m (-57.2%) | $-19.2m (-64.4%) | -23484.5% (-40.3%) | $-1.43 (-13.5%) |
| 2018 | $1.4m (1575.0%) | $-44.8m (-126.9%) | $-40.7m (-111.4%) | -3180.6% (86.5%) | $-1.42 (0.7%) |
| 2019 | $2.9m (106.7%) | $-123.8m (-176.8%) | $-119.8m (-194.7%) | -4258.9% (-33.9%) | $-2.88 (-102.8%) |
| 2020 | $536.0k (-81.6%) | $-142.1m (-14.7%) | $-132.4m (-10.5%) | -26510.1% (-522.5%) | $-2.76 (4.2%) |
| 2021 | $262.0k (-51.1%) | $-142.1m (-0.0%) | $-126.7m (4.3%) | -54235.1% (-104.6%) | $-1.97 (28.6%) |
| 2022 | $1.7m (551.9%) | $-148.8m (-4.7%) | $-123.1m (2.8%) | -8714.2% (83.9%) | $-1.57 (20.3%) |
| 2023 | $0 (-100.0%) | $-208.4m (-40.0%) | $-156.6m (-27.1%) | — | $-1.20 (23.6%) |
| 2024 | $10.1m | $-220.7m (-5.9%) | $-228.3m (-45.8%) | -2180.5% | $-0.86 (28.3%) |
| 2025 | $75.4m (644.9%) | $-287.5m (-30.3%) | $-302.6m (-32.5%) | -381.4% (82.5%) | $-1.08 (-25.6%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.